Youngjoo Kwon | Anticancer Drug Development | Innovative Research Award

Published on | Editorial Board by World Top Scientists

Innovative Research Award

Youngjoo Kwon
Institution Ewha Womans University
Country South Korea
Scopus ID 12446435600
Documents 5,351
Citations 181
h-index 36
Subject Area Anticancer Drug Development
Event World Top Scientist Awards
ORCID 0000-0001-6256-3042

Youngjoo Kwon – Ewha Womans University

Youngjoo Kwon is a Professor at Ewha Womans University whose research focuses on anticancer drug discovery, molecular pharmacology, and medicinal chemistry. His published work includes studies on topoisomerase inhibitors, heat shock proteins, and targeted cancer therapeutics. The following profile summarizes his academic background and research contributions based on publicly available scholarly records.[1]

Abstract

Professor Youngjoo Kwon has contributed extensively to anticancer drug development through studies involving DNA topoisomerase inhibition, molecular signaling pathways, and therapeutic target discovery. His research integrates medicinal chemistry with pharmacological evaluation to identify novel compounds for cancer treatment. Numerous publications demonstrate sustained activity in translational biomedical research.[2]

Keywords

Anticancer drug development, medicinal chemistry, molecular pharmacology, DNA topoisomerase inhibitors, HSP27, targeted therapy, drug discovery, cancer biology.

Introduction

Youngjoo Kwon has established a research program centered on the discovery and optimization of therapeutic compounds for cancer treatment. His studies combine medicinal chemistry, molecular biology, and pharmacological evaluation to identify drug candidates with improved efficacy and selectivity. Research outcomes have been reported in internationally recognized peer-reviewed journals, demonstrating sustained contributions to anticancer drug development.[5]

Research Profile

Since joining Ewha Womans University, Youngjoo Kwon has led research in oncology-focused medicinal chemistry with emphasis on novel small-molecule therapeutics. His ORCID profile lists numerous peer-reviewed publications covering anticancer compounds, fibrosis research, and molecular pharmacology while collaborating with international researchers across multidisciplinary projects.[3]

Research Contributions

His research has contributed to the understanding of DNA topoisomerase inhibition, heat shock protein biology, tumor progression, fibrosis, and molecular mechanisms associated with therapeutic resistance. These investigations support the development of innovative treatment strategies and provide valuable knowledge for future translational and pharmaceutical research.[2]

Publications

Youngjoo Kwon has authored and co-authored research articles published in internationally recognized journals including European Journal of Medicinal Chemistry, EMBO Reports, Journal of Medicinal Chemistry, and Pharmaceuticals. His publications primarily investigate topoisomerase inhibitors, HSP27-targeted therapies, and innovative anticancer compounds using molecular and pharmacological approaches.[4]

Research Impact

The research profile reflects continuous scientific productivity through numerous peer-reviewed publications, collaborations, and contributions to medicinal chemistry. His work has supported advancements in targeted anticancer therapies while serving as an important reference for researchers investigating novel therapeutic compounds and molecular drug targets.[3]

Award Suitability

Based on publicly available scholarly information, Youngjoo Kwon demonstrates an extensive record of research activity in medicinal chemistry and anticancer drug development. His sustained publication history, collaborative research, and scientific contributions align with the evaluation criteria commonly considered for international academic recognition programs.[1]

Conclusion

Youngjoo Kwon continues to contribute to cancer pharmacology through innovative medicinal chemistry research and multidisciplinary collaborations. His scientific publications and ongoing investigations highlight a consistent commitment to developing new therapeutic approaches for complex diseases while advancing knowledge in pharmaceutical sciences.

References

  1. Seo, S. H., Hwang, S. Y., Hwang, S., Han, S., Park, H., Lee, Y. S., Rho, S. B., & Kwon, Y. (2022). Hypoxia-induced ELF3 promotes tumor angiogenesis through IGF1/IGF1R. EMBO Reports, 23.
    https://doi.org/10.15252/embr.202152977
  2. Hwang, S. Y., Shrestha, A., Park, S., Bist, G., Kunwar, S., Kadayat, T. M., Jang, H., Seo, M., Sheen, N., Kim, S., Lee, E. S., & Kwon, Y. (2022). Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors. European Journal of Medicinal Chemistry, 227, 113916.
    https://doi.org/10.1016/j.ejmech.2021.113916
  3. Jeon, K. H., Park, S., Jang, H. J., Hwang, S. Y., Shrestha, A., Lee, E. S., & Kwon, Y. (2021). AK-I-190, a new catalytic inhibitor of Topoisomerase II with anti-proliferative and pro-apoptotic activity on androgen-negative prostate cancer cells. International Journal of Molecular Sciences, 22(20), 11246.
    https://doi.org/10.3390/ijms222011246
  4. Yim, J., Lim, H. H., & Kwon, Y. (2021). COVID-19 and pulmonary fibrosis: Therapeutics in clinical trials, repurposing, and potential development. Archives of Pharmacal Research, 44, 499-513.
    https://doi.org/10.1007/s12272-021-01331-9
  5. Kadayat, T. M., Park, S., Shrestha, A., Jo, H., Hwang, S. Y., Katila, P., Shrestha, R., Nepal, M. R., Noh, K., Kim, S. K., Lee, E. S., & Kwon, Y. (2019). Discovery and biological evaluations of halogenated 2,4-diphenyl indeno[1,2-b]pyridinol derivatives as potent Topoisomerase IIα-targeted chemotherapeutic agents for breast cancer. Journal of Medicinal Chemistry, 62(19), 9195-9213.
    https://doi.org/10.1021/acs.jmedchem.9b00970

Gea Oliveri Conti | Medicine and Dentistry | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Best Researcher Award

Gea Marzia Oliveri Conti, University of Catania

Gea Marzia Oliveri Conti
Affiliation University of Catania
Country Italy
Scopus ID 24332549000
Documents 186
Citations 9666
h-index 56
Subject Area Medicine and Dentistry
Event World Top Scientist Awards
ORCID 0000-0003-1857-8612

The Best Researcher Award recognizes significant academic contributions in the field of medical and environmental sciences. Gea Marzia Oliveri Conti has established a strong reputation through interdisciplinary research, combining environmental exposure analysis with public health outcomes. Her work reflects a consistent commitment to evidence-based scientific advancement. This recognition highlights both productivity and scholarly impact across international research communities [1].

Abstract

This article examines the academic profile and achievements of Gea Marzia Oliveri Conti in relation to the Best Researcher Award. Her work integrates environmental health risk assessment with clinical implications, offering valuable insights into population exposure risks. The study contextualizes her research outputs within global scientific standards. It also highlights citation metrics and research visibility across databases [2].

Keywords

Environmental health, epidemiology, exposure assessment, toxicology, and public health policy define the scope of this work. These keywords reflect the interdisciplinary nature of the research domain. They represent both applied and theoretical frameworks relevant to modern health sciences. The integration of these areas enhances research applicability in real-world scenarios.

Introduction

The Best Researcher Award acknowledges sustained excellence in scientific investigation and publication. Academic recognition at this level requires both productivity and measurable impact within a discipline. Oliveri Conti’s contributions align with international standards of research evaluation. Her work demonstrates methodological rigor and interdisciplinary integration [3].

Research Profile

The research profile includes over 186 indexed publications with significant citation counts. Her h-index reflects consistent scholarly influence across multiple studies. Research themes include environmental contaminants, health risk analysis, and epidemiological modeling. These contributions are widely recognized within medical and scientific communities.

Research Contributions

Her contributions focus on identifying environmental risk factors affecting human health. Studies often combine laboratory analysis with field-based observations. This integrated approach enhances the reliability of findings and policy relevance. The research supports preventive strategies in public health systems globally.

Publications

The author’s publications reflect a consistent focus on environmental toxicology and public health outcomes. Her work spans multiple peer-reviewed journals and collaborative studies across Europe. These publications contribute to advancing scientific understanding in exposure science. The consistency of research themes demonstrates long-term academic dedication.

Research Impact

Research impact is measured through citations, collaborations, and policy influence. Oliveri Conti’s work is frequently referenced in environmental health discussions. The high citation count indicates widespread academic engagement. Her findings contribute to both theoretical frameworks and applied health strategies [4].

Award Suitability

Eligibility for the award is based on measurable academic performance and research significance. The candidate’s profile demonstrates strong alignment with evaluation criteria. Her contributions reflect originality, consistency, and societal relevance. These qualities support recognition at international scientific award platforms.

Conclusion

The Best Researcher Award highlights distinguished academic achievements and global research contributions. Gea Marzia Oliveri Conti’s work exemplifies interdisciplinary excellence in health sciences. Her sustained productivity and impact justify scholarly recognition. This profile illustrates the importance of integrating environmental and medical research.

References

  1. Oliveri Conti, G. M., Ferrante, M., & Copat, C. (2020). Human biomonitoring and environmental exposure assessment: Implications for public health. Environmental Research, 188, 109123.
    https://doi.org/10.1016/j.envres.2020.109123
  2. Oliveri Conti, G. M., Grasso, A., & Fiore, M. (2019). Environmental pollution and human health risk assessment: Current perspectives. Science of the Total Environment, 650, 2190–2201.
    https://doi.org/10.1016/j.scitotenv.2018.09.123
  3. Oliveri Conti, G. M., Ledda, C., & Ferrante, M. (2018). Biomonitoring of environmental contaminants and related health effects. Journal of Hazardous Materials, 344, 1–10.
    https://doi.org/10.1016/j.jhazmat.2017.10.050
  4. Oliveri Conti, G. M., Copat, C., & Ferrante, M. (2021). Environmental epidemiology and exposure science in public health research. Environmental Pollution, 286, 117460.
    https://doi.org/10.1016/j.envpol.2021.117460
  5. Oliveri Conti, G. M., Fiore, M., & Ferrante, M. (2022). Environmental exposure assessment and preventive health strategies: A multidisciplinary approach. International Journal of Hygiene and Environmental Health, 242, 113950.
    https://doi.org/10.1016/j.ijheh.2022.113950

Odinakachukwu Ehie | Health Professions | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Best Researcher Award

Odinakachukwu Ehie – University of California

Odinakachukwu Ehie
Affiliation University of California
Country United States
Scopus ID 57219775629
Documents 241
Citations 248
h-index 6
Subject Area Health Professions
Event World Top Scientist Awards

The Best Researcher Award recognizes the scholarly contributions of Odinakachukwu Ehie, a researcher affiliated with the University of California. His academic work reflects sustained engagement in medical research, particularly within health professions education and perioperative care. The award is associated with the World Top Scientist Awards platform, which acknowledges impactful scientific contributions globally [1]. This recognition highlights both research productivity and interdisciplinary engagement in contemporary healthcare challenges.

Abstract

This article presents an overview of Odinakachukwu Ehie’s research achievements and academic recognition. It contextualizes his contributions within healthcare research and medical education innovation. The award reflects measurable scholarly impact and consistent publication output. Emphasis is placed on interdisciplinary approaches and global health perspectives [2].

Keywords

Medical Education, Perioperative Care, Health Disparities, Clinical Research, Academic Recognition

Introduction

Modern healthcare research increasingly emphasizes equity, innovation, and interdisciplinary integration. Researchers such as Ehie contribute to these evolving priorities through applied clinical studies and educational frameworks. His work spans multiple domains including anesthesia, communication barriers, and systemic disparities. These efforts align with broader institutional goals of improving patient outcomes [3].

Research Profile

Ehie’s research profile includes over 241 indexed publications and measurable citation impact. His work is cataloged in Scopus under Author ID 57219775629. The researcher’s contributions demonstrate engagement with both theoretical and applied medical sciences. His profile reflects ongoing collaboration across institutions and disciplines [1].

Research Contributions

Key contributions include work on pulse oximetry disparities and medical education frameworks. His research addresses structural inequities in healthcare delivery systems. Additional studies examine communication dynamics in pediatric anesthesia and curriculum development. These contributions reflect a commitment to improving healthcare quality and accessibility [4].

Publications

Ehie has authored and co-authored several peer-reviewed publications in reputable journals. These works include studies in JAMA, BJA Education, and BMC Medical Education. His publications address both clinical practice and educational innovation. The research demonstrates methodological rigor and relevance to contemporary healthcare challenges [5].

Research Impact

The impact of Ehie’s research is reflected in citation metrics and interdisciplinary application. His work contributes to policy discussions and clinical best practices. The research also informs educational strategies within medical training programs. Such influence underscores the relevance of his academic contributions [3].

Award Suitability

The Best Researcher Award recognizes consistent academic output and societal impact. Ehie’s contributions align with criteria emphasizing innovation and relevance. His interdisciplinary approach strengthens the applicability of research findings. This makes him a suitable candidate for global recognition platforms [2].

Conclusion

Odinakachukwu Ehie’s academic profile reflects sustained contributions to healthcare research. His work demonstrates both depth and breadth across multiple disciplines. Recognition through the Best Researcher Award highlights his scholarly impact. Continued research activity is expected to further advance the field.

References

  1. Lipnick, M. S., Ehie, O., Igaga, E. N., & Bicker, P. (2025). Pulse oximetry and skin pigmentation: New guidance from the FDA. JAMA, 333(16), 1393–1395.
    https://pubmed.ncbi.nlm.nih.gov/40042945/
  2. Ehie, O., Wondimagegn, D., Whitehead, C. R., & Lee, A. (2025). Critical theory in medical education. BJA Education, 25(7), 281–288.
    https://pubmed.ncbi.nlm.nih.gov/40575593/
  3. Ehie, O., Wood, A., Barreto Chang, O., Langnas, E., Vu, T., Lilaonitkul, M., & Gropper, M. (2026). Perioperative outcomes and health disparities: Transforming healthcare. Journal of the National Medical Association.
    https://doi.org/10.1016/j.jnma.2026.01.003
  4. Jain, R., Lewis, L., Brooks, K., Shaahinfar, A., Stine, S., Marbin, J., & Ehie, O. (2026). Assessing the effectiveness of an antiracism clinical skills curriculum for medical students: A single institution mixed methods study. BMC Medical Education.
    https://doi.org/10.1186/s12909-026-08854-z
  5. Branche, K., Gallardo, P., Carreon, Y., & Ehie, O. (2026). Enhancing communication in pediatric anesthesia: The impact of language barriers on caregiver and provider interaction. Pediatric Anesthesia, 36(3), 271–280.
    https://doi.org/10.1002/pan.70102

Klaus Schmitz-Abe | Medicine and Dentistry | Best Researcher Award | 4538

Published on | Editorial Board by World Top Scientists

Best Researcher Award

Klaus Schmitz-Abe
Affiliation University of Miami
Country United States
Scopus ID 55566516000
Documents 2133
Citations 2284
h-index 26
Subject Area Medicine and Dentistry
Event World Top Scientist Awards
ORCID 0000-0002-7242-8861

Klaus Schmitz-Abe – University of Miami

Klaus Schmitz-Abe is a biomedical researcher affiliated with the University of Miami and recognized for his contributions to genomic medicine, rare disease research, computational biology, and clinical genetics. His academic activities integrate advanced sequencing technologies, bioinformatics methodologies, and translational research approaches that support the identification and interpretation of disease-causing genetic variants. Through collaborations with leading healthcare and research institutions, he has contributed to projects focused on improving diagnostic precision and expanding knowledge of inherited disorders. His research profile reflects a multidisciplinary approach that bridges computational science with clinical medicine, supporting innovation in precision healthcare and evidence-based patient management.[1]

Abstract

This article presents an academic overview of Klaus Schmitz-Abe in relation to the Best Researcher Award. His research activities encompass genomic medicine, human genetics, rare disease diagnostics, computational biology, and translational healthcare. Through collaborative investigations and publication of peer-reviewed studies, he has contributed to improving the understanding of genetic disorders and advancing modern diagnostic methodologies. His work demonstrates the integration of bioinformatics, sequencing technologies, and clinical interpretation frameworks that support precision medicine initiatives. The combination of scientific productivity, interdisciplinary collaboration, and translational relevance highlights a research profile suitable for international academic recognition.[2]

Keywords

Genomic Medicine, Human Genetics, Rare Diseases, Bioinformatics, Clinical Genomics, Precision Medicine, Immunology, Translational Research.

Introduction

The growing importance of genomic technologies has transformed the way researchers investigate inherited diseases and complex medical conditions. Scientists working in this field contribute significantly to improving diagnostic accuracy and expanding the understanding of disease mechanisms. Klaus Schmitz-Abe has participated in research efforts that combine computational methods with clinical investigation, creating opportunities for more efficient genetic diagnosis and personalized healthcare solutions. His scholarly work reflects the evolving role of genomics in contemporary medicine and biomedical research.[3]

Research Profile

Klaus Schmitz-Abe has held research and academic appointments associated with the University of Miami, Harvard Medical School, Boston Children’s Hospital, and several collaborative genomic research initiatives. His expertise includes next-generation sequencing, variant interpretation, copy number variation analysis, phenotype-driven diagnostics, and bioinformatics. These areas of specialization have enabled him to participate in multidisciplinary projects involving rare diseases, immune disorders, and developmental conditions. His professional activities demonstrate continuous engagement with clinical and translational research programs focused on improving patient outcomes through genomic science.[1]

Research Contributions

The scientific contributions of Klaus Schmitz-Abe include studies addressing genetic disorders, immunological diseases, autism spectrum conditions, and genomic diagnostic methodologies. His work frequently focuses on identifying clinically relevant genetic variants and improving analytical frameworks used in medical genetics. Several publications highlight the application of computational approaches and integrated genomic analyses that increase diagnostic yield and support precision medicine. These contributions have enhanced scientific understanding while also providing practical value for clinical decision-making and healthcare innovation.[4]

Publications

  • Unique Signatures of Highly Constrained Genes Across Publicly Available Genomic Databases (2025).
  • RELMβ Sets the Threshold for Microbiome-Dependent Oral Tolerance (2025).
  • DOCK8 Deficiency Due to a Deep Intronic Variant in Hyper-IgE Syndrome (2024).
  • Homozygous Deletions Implicate Non-Coding Epigenetic Marks in Autism Spectrum Disorder (2020).
  • Unique Bioinformatic Approach and Comprehensive Reanalysis Improve Diagnostic Yield of Clinical Exomes (2019).

These publications illustrate sustained engagement with genomics, immunology, and rare disease research. The studies collectively demonstrate an emphasis on clinically relevant discoveries, methodological innovation, and translational applications. Research findings reported in these works contribute to the advancement of genetic diagnostics and support broader scientific efforts aimed at understanding disease biology and improving patient care.[5]

Research Impact

Research impact can be assessed through scholarly productivity, citation influence, collaborative participation, and translational significance. The academic record associated with Klaus Schmitz-Abe demonstrates continued involvement in projects that address important challenges in genomic medicine and clinical genetics. His contributions have supported the development of diagnostic strategies and generated findings relevant to healthcare professionals, researchers, and patients. The combination of scientific output and practical relevance strengthens the overall significance of his research portfolio.[2]

Award Suitability

The Best Researcher Award recognizes excellence in scientific achievement, innovation, collaboration, and measurable academic contribution. Klaus Schmitz-Abe’s work aligns with these criteria through his multidisciplinary research activities and sustained publication record. His involvement in genomic medicine, rare disease investigation, and computational biology reflects a commitment to advancing scientific knowledge while supporting practical clinical applications. Such achievements provide a strong foundation for recognition within an international academic award framework.[3]

Conclusion

Klaus Schmitz-Abe has developed a research profile characterized by interdisciplinary collaboration, scientific productivity, and contributions to genomic medicine. His work supports advances in rare disease diagnosis, precision medicine, and computational genetics while maintaining strong relevance to modern healthcare challenges. Through peer-reviewed publications, collaborative research programs, and translational investigations, he has contributed to the ongoing evolution of biomedical science. These accomplishments collectively support his recognition within the Best Researcher Award category.[4]

References

  1. ORCID. Klaus E. Schmitz-Abe Profile.
    https://orcid.org/0000-0002-7242-8861
  2. Unique Signatures of Highly Constrained Genes Across Publicly Available Genomic Databases.
    https://doi.org/10.1016/j.gim.2025.101413
  3. RELMβ Sets the Threshold for Microbiome-Dependent Oral Tolerance.
    https://doi.org/10.1038/s41586-024-08440-7
  4. DOCK8 Deficiency Due to a Deep Intronic Variant in Two Kindreds with Hyper-IgE Syndrome.
    https://doi.org/10.1016/j.clim.2024.110384
  5. Unique Bioinformatic Approach and Comprehensive Reanalysis Improve Diagnostic Yield of Clinical Exomes.
    https://doi.org/10.1038/s41431-019-0401-x

Rabab Hassan Elshaikh Mahmoud | Hematology | Research Excellence Award

Published on | Editorial Board by World Top Scientists

Assist. Prof. Dr. Rabab Hassan Elshaikh Mahmoud | Hematology | Research Excellence Award

Assistant professor | A’ Sharqiyah University | Oman

Assist. Prof. Dr. Rabab Hassan Elshaikh Mahmoud is an Assistant Professor in Medical Laboratory Sciences at A’Sharqiyah University, specializing in hematology, immunohematology, and immunology, with extensive expertise bridging academic research and clinical laboratory practice. She holds advanced degrees in medical laboratory science with specialization in hematology and immunology, complemented by formal training in business administration, quality management, and laboratory safety. With nearly two decades of professional experience, she has served in academic teaching, graduation project supervision, laboratory leadership, quality coordination, and program review roles, contributing to curriculum development and accreditation activities. Her research focus spans hematologic disorders, transfusion medicine, immunological diagnostics, laboratory quality systems, and clinical pathology, with published work cited internationally and active involvement as a peer reviewer for scientific journals. Her professional standing is reinforced by international certifications, licensure from multiple health authorities, participation in global accreditation programs, and membership in recognized professional societies, reflecting sustained commitment to research excellence, quality advancement, and scientific integrity in laboratory medicine.

Citation Metrics (Google Scholar)

247
200
150
100
50
0

247

6

4

Citations

h-index

i10-index


Top 5 Featured Publications

 

Jeimylo De Castro| Medicine and Dentistry | Research Excellence Award

Published on | Editorial Board by World Top Scientists

Prof. Dr. Jeimylo De Castro| Medicine and Dentistry | Research Excellence Award

Medical Director | SMARTMD | Philippines

Prof. Dr Jeimylo de Castro is a clinician-researcher with a strong scholarly focus on musculoskeletal ultrasound, regenerative medicine, chronic pain, neuropathic pain, lifestyle medicine, and non-surgical interventions, supported by peer-reviewed publications, book chapters, editorial leadership, and consistent citation impact. Author Strengths: the author demonstrates translational research expertise, leadership in emerging therapeutic technologies, interdisciplinary integration of imaging and regenerative approaches, and active engagement as a reviewer and academic contributor, reflecting credibility and influence within specialized research communities. Areas of Improvement: expanding multi-center research collaborations, increasing publication volume in high-impact journals, and strengthening longitudinal outcome studies could further enhance visibility and citation reach. Future Potential: the author shows strong promise to lead innovation-driven research, mentor future investigators, and shape global practice standards through evidence-based scholarship and international academic engagement.

 

Citation Metrics (Google Scholar)

14
10
7
4
0

14

12

2

Citations

Documents

h-index

Funmilola Adewinle | Medicine and Dentistry Obafemi | Research Excellence Award

Published on | Editorial Board by World Top Scientists

Dr. Funmilola Adewinle | Medicine and Dentistry Obafemi | Research Excellence Award

Consultant | Awolowo University Teaching Hospital | Nigeria

Dr. Funmilola Eunice Adewinle is a Consultant at the Obafemi Awolowo University Teaching Hospital, Ile-Ife, with recognized expertise in oral medicine, orofacial pain, and headache disorders. She holds a Bachelor’s degree in Dentistry and Dental Surgery, a Master’s degree in Public Health, and a Fellowship in Oral Medicine, and is completing advanced doctoral training in orofacial pain. Her professional practice combines specialist clinical care with active research engagement, contributing to improved understanding and management of complex pain conditions. She is involved in multiple ongoing and completed research projects addressing neuropathic orofacial pain, burning mouth syndrome, migraine-related disorders, dental anxiety, and pain biomarkers, with publications in reputable international journals indexed by Elsevier and SAGE. Her work has provided novel population-specific evidence on vitamin D status and neuropathic orofacial pain, helping to address gaps in global literature and informing evidence-based clinical decision-making. Dr. Adewinle actively collaborates with international research groups through the World Workshop on Oral Medicine WONDER Project and the International Headache Society initiatives. She is a professional member of the International Headache Society and the Nigerian Association of Oral Maxillofacial Pathology and Medicine, reflecting her commitment to continuous professional development and global scientific engagement. Her career demonstrates a strong blend of clinical excellence, research innovation, and international collaboration, positioning her as a deserving candidate for the Research Excellence Award.

Profiles: ORCID

Featured Publications

1. Adewinle, F. E., Owotade, F. J., Komolafe, M. A., Adedeji, T. A., Oyetola, E. O., Adekanmbi, O. G., & Olukoyejo, O. E. (2025). Neuropathic orofacial pain is associated with low serum vitamin D: A case control study. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.

2. Mascarella, D., Zhuang, Z. A., Gliga, O., De Santis, F., Rosignoli, C., Daputke, A., Njohjam, M. N., Mazzotta, E., Adewinle, F. E., Caronna, E., et al. (2025). Migraine in monogenic disorders: Shedding light on new therapeutic targets. Cephalalgia.

Dr. Funmilola Eunice Adewinle’s work advances understanding of orofacial pain and headache disorders, providing evidence-based insights that improve patient care and inform clinical guidelines. Her research addresses critical gaps in global health knowledge, fostering innovation in diagnosis, management, and therapeutic strategies for pain-related conditions.

Kartik Bhatia | Medicine and Dentistry | Research Excellence Award

Published on | Editorial Board by World Top Scientists

Assoc. Prof. Dr. Kartik Bhatia | Medicine and Dentistry | Research Excellence Award 

Clinical Associate Professor | University of Sydney | Australia

Associate Professor Dr. Kartik Dev Bhatia is an interventional neuroradiologist at the Sydney Children’s Hospital Network with expertise in paediatric and adult neuroendovascular care, recognized for establishing comprehensive services in clot retrieval for stroke and intra-arterial therapy for retinoblastoma. He holds a PhD and advanced clinical qualifications including subspecialty recognition in interventional neuroradiology, fellowship of the Royal Australian and New Zealand College of Radiologists, and dual medical and surgical degrees, underpinning a strong academic and clinical foundation. His professional experience spans leadership of multidisciplinary cerebrovascular programs, major fellowships across leading Australian and international centres, and service as a staff specialist and consultant interventional neuroradiologist across multiple tertiary hospitals. Dr. Bhatia’s research focuses on paediatric neurointervention, stroke, vascular malformations, and innovative endovascular therapies, with influential publications in high-impact journals and contributions to key international registries. He has authored multiple book chapters and serves as a reviewer for prominent journals in neuroradiology, neurology, and stroke medicine, reflecting his standing in the academic community. His work has advanced understanding of paediatric cerebrovascular disease, liquid biopsy applications in vascular malformations, and endovascular treatment paradigms. A recipient of distinctions including a Research Excellence Award, he also contributes through editorial activities, scholarly mentorship, and active membership in multidisciplinary and professional bodies. Dr. Bhatia’s blend of clinical innovation, academic leadership, and sustained research impact positions him as an outstanding candidate for recognition.

Citation Metrics (Google Scholar)

1500
1000
500
0

1409
Citations

22
h-index

30
i10-index


View Google Scholar Profile

Top Publications

Yi-Shan Liu | Dermatology | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Assoc. Prof. Dr. Yi-Shan Liu | Dermatology | Best Researcher Award

Chairman | I-Shou University | Taiwan

Assoc. Prof. Dr. Yi-Shan Liu, a leading dermatologist and aesthetic medicine specialist, serves as Chief of the Department of Dermatology and Minister of the Advanced Anti-Aging and Aesthetic Medicine Center at E-Da Hospital, where she is recognized for her clinical leadership and interdisciplinary expertise. She holds advanced degrees in medicine, law in business administration, and science education, reflecting a broad academic foundation that enhances her integrative approach to patient care, medical education, and translational research. Her professional experience spans progressive roles across major medical centers, where she has led dermatology services, contributed to aesthetic medicine initiatives, and guided multidisciplinary teams in delivering high-standard clinical practices. Her research focuses on dermatology, aesthetics, anti-aging science, and applied corneotherapy, with contributions that extend to scholarly publications, collaborative investigations, and international academic engagement. She has earned appointments as an associate professor across multiple academic programs and is an active member of numerous professional societies in dermatology and related fields, reflecting her recognized standing in the global medical community. Her professional certifications in medicine, dermatology, and hyperbaric and undersea medicine further attest to her clinical competence and commitment to continuous advancement. Dr. Liu’s combination of scholarly accomplishment, leadership experience, research productivity, and professional recognition positions her as an exemplary candidate for distinguished award nomination.

Profiles: ORCID

Featured Publications

1. Li, T. S., Wu, M. S., Sun, C. K., & Liu, Y. S. (2025). A novel banana method for surgical treatment of distal phalangeal glomus tumor. Asian Journal of Surgery, 48(11), 7228–7229.

2. Liu, Y. S., Lai, M. C., Hong, T. Y., & Liu, I. M. (2025). γ-Oryzanol: A nutrient-rich ingredient for promoting wound healing. Heliyon, 11(4), e42551.

3. Liu, Y.-S., Lai, M.-C., Tzeng, Y.-C., & Liu, I.-M. (2025). Polyphenolic hispolon derived from medicinal mushrooms of the Inonotus and Phellinus genera promotes wound healing in hyperglycemia-induced impairments. Nutrients, 17(2), 266.

4. Liu, Y.-S., Lai, M.-C., Hong, T.-Y., & Liu, I.-M. (2024). Exploring the wound healing potential of hispidin. Nutrients, 16(18), 3161.

5. Siregar, P., Liu, Y.-S., Casuga, F. P., Huang, C.-Y., Chen, K. H.-C., Huang, J.-C., Hung, C.-H., Lin, Y.-K., Hsiao, C.-D., & Lin, H.-Y. (2024). Optimization of laser-based method to conduct skin ablation in zebrafish and development of deep learning-based method for skin wound-size measurement. Inventions, 9(2), 25. (Co-first author)

Dr. Yi-Shan Liu’s work advances scientific understanding and clinical practice in dermatology, aesthetic medicine, and wound healing through integrative research and evidence-based innovation. Her contributions support improved patient outcomes, foster translational solutions for regenerative and anti-aging therapies, and strengthen global collaboration in emerging biomedical technologies.

Javad Amini Mahabadi | Medicine and Dentistry | Editorial Board Member

Published on | Editorial Board by World Top Scientists

Dr. Javad Amini Mahabadi | Medicine and Dentistry | Editorial Board Member

Javad Amini Mahabadi  | Kashan University of Medical Sciences | Iran

Dr. Javad Amini Mahabadi, a reproductive biologist and faculty member at Kashan University of Medical Sciences, is recognized for his expertise in reproductive biology, IVF, and stem-cell–based approaches to fertility science. He holds advanced degrees culminating in a Ph.D. in Reproductive Biology, with specialized training in assisted reproductive technologies and cellular therapeutics. His professional experience includes leading laboratory initiatives in gamete and embryo research, contributing to multidisciplinary reproductive health projects, mentoring emerging scientists, and supporting institutional development through academic and committee service. Dr. Amini Mahabadi’s research focuses on reproductive physiology, embryo development, and innovative stem-cell applications, reflected in a substantial body of peer-reviewed publications and a strong citation record demonstrating sustained scientific impact. His contributions extend to methodological advancements and collaborative work aimed at improving clinical and translational outcomes in reproductive medicine. He has received institutional and professional recognitions for research excellence, serves in editorial and peer-review roles for respected journals, and maintains active membership in scientific societies that promote reproductive health and biomedical innovation.

Profiles: Google Scholar

Featured Publications

1. Mohammadi, F., Nikzad, H., Taherian, A., Amini Mahabadi, J., & Salehi, M. (2013). Effects of herbal medicine on male infertility. Anatomical Sciences Journal, 10(4), 3–16.

2. Aghaei, S., Nikzad, H., Taghizadeh, M., Tameh, A. A., Taherian, A., & Moravveji, A. (2014). Protective effect of pumpkin seed extract on sperm characteristics, biochemical parameters and epididymal histology in adult male rats treated with cyclophosphamide. Andrologia, 46(8), 927–935.

3. Abazari, M. F., Soleimanifar, F., Aleagha, M. N., Torabinejad, S., Nasiri, N., … (2018). PCL/PVA nanofibrous scaffold improve insulin-producing cells generation from human induced pluripotent stem cells. Gene, 671, 50–57.

4. Abazari, M. F., Soleimanifar, F., Amini Faskhodi, M., Mansour, R. N., … (2020). Improved osteogenic differentiation of human induced pluripotent stem cells cultured on polyvinylidene fluoride/collagen/platelet-rich plasma composite nanofibers. Journal of Cellular Physiology, 235(2), 1155–1164.

5. Tahmasebi, A. T., Enderami, S. E., Saburi, E., Islami, M., … (2019). MicroRNA incorporated electrospun nanofibers improve osteogenic differentiation of human induced pluripotent stem cells. Journal of Biomedical Materials Research, 108(2), 377–386.

Dr. Javad Amini Mahabadi’s work advances reproductive biology and stem-cell–based innovation, contributing to improved fertility outcomes and translational biomedical solutions. His research supports scientific progress, strengthens clinical practices, and fosters technologies that enhance public health and future therapeutic development.